Skip to content

EVOFEM BIOSCIENCES, INC.

EVFM

CIK 0001618835

← back to feed
Revenue (TTM)
$11.52M
+4.2% YoY Q1 May 2026
Net Income (TTM)
−$7.86M
+104.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.07
+100.0% YoY Q1 May 2026
Gross Margin
78.9%
Q1 May 2026
Operating Margin
-39.4%
Q1 May 2026
Net Margin
-68.2%
Q1 May 2026
Free Cash Flow (TTM)
−$2.04M
Q1 May 2026
Cash
$1.49M
Q1 May 2026
Total Debt
$2.96M
Q1 May 2026
Shares Outstanding
132.53M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings